Position in GRAL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,151,322
+$403,816 QoQ
Shares Held
31,512
-6.8% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 374 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $687,077,231 across 23 Diagnostics & Research names. GRAL ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
633,668 | $317,695,787 | |
| 2 | DHR |
Danaher Corp /De/
|
678,049 | $129,154,772 | |
| 3 | ILMN |
Illumina, Inc.
|
446,598 | $78,525,324 | |
| 4 | DGX |
Quest Diagnostics Inc
|
123,220 | $26,116,476 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
134,890 | $26,063,445 | |
| 6 | LH |
Labcorp Holdings Inc.
|
88,570 | $24,799,600 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
30,389 | $15,997,984 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
26,941 | $14,267,682 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,151,322 | 31,512 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,747,506 | 33,814 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,198,411 | 37,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,854,262 | 48,271 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,773,783 | 34,496 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $803,895 | 31,476 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $624,605 | 34,992 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $406,056 | 29,510 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||